Viewing Study NCT04699669


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:50 PM
Study NCT ID: NCT04699669
Status: COMPLETED
Last Update Posted: 2021-01-07
First Post: 2020-12-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
Sponsor: Caliway Biopharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module